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The use of low concentrations (optimally 2.5 to 3.5 g/ml, depending on top agar thickness) of ampicillin in
the bottom agar of the plate allows for formation of highly visible plaques of bacteriophages which otherwise
form extremely small plaques or no plaques on Escherichia coli lawns. Using this method, we were able to obtain
plaques of newly isolated bacteriophages, propagated after induction of prophages present in six E. coli
O157:H strains which did not form plaques when standard plating procedures were employed.
In the second half of 20th century, bacteriophages were
among the most important models in molecular biology. How-
ever, at the end of that century, after learning principles of
molecular biology using bacteriophage models, these viruses
became considered less attractive research subjects due to de-
velopment of sophisticated systems for studying eukaryotic
cells. Nevertheless, recent years may be recognized as a new
era in bacteriophage biology. This is because of several unex-
pected findings, which demonstrated that viruses infecting bac-
terial cells may be very important not only in basic biological
studies but also in medicine and biotechnology (for reviews,
see references 7 and 38). The breakthroughs included discov-
eries that many toxins (including the vast majority of verotox-
ins) produced by bacteria pathogenic to animals and humans
are encoded in bacteriophage genomes (20, 37); that bacterio-
phages can be used in vaccination and in specific kinds of
therapy (10); that bacteriophages can be extremely dangerous
for bioprocesses based on bacterial activities in biotechnolog-
ical factories (25, 35) but also may be employed in genetic
engineering and biotechnology in a very sophisticated manner
(10, 28); and finally that they are the most abundant creatures
worldwide, thus playing an extremely important ecological role
(9, 12, 19, 39).
The growing interest in various aspects of phage biology
must be connected to isolation and characterization of newly
discovered viruses. However, contrary to well-investigated
model bacteriophages, in most cases of newly isolated phages
there are problems with their propagation under laboratory
conditions. This is partially due to the fact that the number of
indicator strains used in laboratories is rather limited and var-
ious limitations arise from using nonpermissive or suboptimal
hosts. The first step in getting an uncontaminated lysate of a
particular bacteriophage strain is obtaining single plaques on
the host lawn. However, this first and obligatory stage of anal-
ysis may be, in fact, a limiting step as there are many examples
(though mostly unpublished) of serious problems with getting
plaques of newly discovered bacteriophages. This problem
seems to be common in the case of lambdoid bacteriophages
(27, 42). We met this problem when investigating phages cod-
ing for Shiga toxins, whose genomes are present as prophages
in chromosomes of some Escherichia coli strains. For example,
phage 24B (stx::cat) (4) and phage ST2-8624 (stx::cat gfp)
from E. coli O157:H7 strain 8624 (obtained from Gail Christie,
Virginia Commonwealth University, Richmond) form either
pinpoint plaques or no plaques, depending on the host strain
and particular conditions of standard titration. Therefore, we
tried to improve phage titration procedures to develop condi-
tions allowing formation of plaques by bacteriophages which
give minute plaques or do not plate at all under standard
laboratory conditions.
MATERIALS AND METHODS
Phage and bacterial strains. The E. coli strains and bacteriophages used in this
work are listed in Table 1.
Bacteriological media. The following media were used. Luria-Bertani (LB)
medium (Roth, Germany) (32) was used for bacterial growth. The same medium,
but supplemented with 1.5% bacteriological agar, was used as a bottom agar for
pouring plates. Top agar consisted of 1% Tryptone (Difco), 0.5% NaCl (POCH,
Poland), and 0.7% bacteriological agar (Becton Dickinson). For experiments in
minimal media, a phosphate-buffered (FB) mineral salt medium, prepared ac-
cording to Teich et al. (36) was used. The bottom and top FB agars contained
1.5% and 0.7% bacteriological agar, respectively. The FB mineral medium was
prepared using chemicals from POCH, Poland, except for citric acid diammo-
nium salt (Sigma). FB plates were poured using 2 concentrated FB medium
mixed with an equal volume of 3% water agar. Top agar consisted of 2
concentrated FB medium mixed with an equal volume of 1.5% water agar. FB
media were supplemented with one of following carbon sources: glucose, glyc-
erol, or succinate (all from Sigma) at final concentrations of 0.2%, 0.4%, and
0.6%, respectively.
Antibiotics. All antibiotics (kanamycin, ampicillin, tetracycline, and chloram-
phenicol [purchased from Sigma]) were tested at the following concentrations:
0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5 and 5.0 g/ml. After preliminary studies,
only concentrations that allowed for the formation of the biggest plaques were
chosen.
Standard phage titration procedure. Phage titration was performed on dis-
posable plastic petri dishes (diameter, 90 mm) (Merck). Twenty-five milliliters of
bottom LB agar plates was used. The indicated amounts of top agar, supple-
mented with 10 mM CaCl2 (Sigma-Aldrich) and 10 mM MgSO4 (Sigma-Aldrich)
and containing the indicated volumes of overnight bacterial culture (according to
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reference 3, modified to vary the amount of bacterial culture used, as described
herein), were poured onto the plate. Five microliters of each serial dilution of a
phage lysate was spotted onto the top agar. When full-plate titration was used,
0.1 ml of phage lysate dilutions was added to 1 ml of a bacterial culture (an
equivalent of 1.6  109  0.2  109 CFU [mean value from three independent
titrations]), which was followed by an addition of 2 or 3 ml of the top agar to the
tube and immediate pouring onto the bottom agar layer. Plates were incubated
at 37°C for 16 h.
Improved phage titration procedure. The procedure was analogous to the
standard phage titration procedure, but the indicated amounts of antibiotics
were added to the bottom agar. Top agar remained free of antibiotic at the time
of pouring. For a droplet titration variant, top agar was poured immediately
before the plates were used.
Plaque size determination. Pictures of plates with bacteriophage plaques were
taken using the FluorS (Bio-Rad) gel documentation system. Diameters of
plaques were measured manually. A photograph of the scale (in millimeters),
taken at the same magnification, was used for calculations.
GT estimation. Generation time (GT) was estimated in liquid cultures by
measurement of optical density at 600 nm (OD600). The GT value was calculated
from the following equation: GT  ln 2/[ln (ODT2/ODT1)/(T2  T1)], where T1
and T2 are times of measurement in hours. The provided data are mean values
from three independent experiments.
RESULTS
When testing different variants of titration conditions, we
found that bacteriophages 	cIb2 (unable to form lysogens) and
T4D (a “wild-type” strain of phage T4) form plaques bigger
than those observed on LB media, when titrated on a host (E.
coli MG1655 [22]) forming a lawn on minimal plates supple-
mented with a carbon source that supports a rapid (GT of
54.3  1.8 min in a liquid culture, as in the case of glucose),
moderate (GT of 81.9  3.6 min in a liquid culture, as in the
case of glycerol), or low (GT of 158.2  14.3 min in a liquid
culture, as in the case of succinate) growth rate (Fig. 1). How-
ever, the effects of reduction of bacterial growth rate using
minimal media on enlarging phage plaques were not dramatic.
Moreover, in host cells cultured in minimal media, lytic devel-
opment of at least some bacteriophages, including T4 and 	, is
impaired, which is observed as significantly lowered burst size
(15, 18, 26). This is also true for T7 phage (see reference 44
and references therein). The lowered burst size does not nec-
essary hamper plaque formation, as this may be partially com-
pensated for by a slower growth of the host. This, in turn, may
result in reduction of adsorption rates due to a lower host
density increase, facilitating phage spreading by a faster and
longer diffusion (2, 5). Knowing that reduction of bacterial
growth rate on plates may provide conditions for formation of
larger bacteriophage plaques, we aimed to slow the host
growth rate down using plates with rich media.
For this purpose, we used relatively low concentrations of
antibiotics, which were added to the bottom agar. The top agar
layer remained free of an antibiotic, what allowed for its slow
diffusion from the bottom layer into the zone of bacterial
growth. Various concentrations of four antibiotics (ampicillin,
chloramphenicol, tetracycline, and kanamycin) were used. E.
coli strain C600 (6) was employed in these experiments as a
host for phage titration, since in preliminary studies we found
FIG. 1. Formation of plaques by bacteriophages 	cIb2 and T4D on
lawns of E. coli MG1655 grown in LB medium or minimal FB medium
supplemented with various carbon sources (0.4% glycerol, 0.2% glu-
cose, or 0.6% succinate). The size scale is shown.
TABLE 1. Bacterial strains and bacteriophages used in this work
Bacterial or phage strain Source or reference
Bacterial strains
E. coli C600......................................6
E. coli MG1655 ...............................22
E. coli O157:H 263.......................Jacek Osek (Department of Microbiology,
National Veterinary Research Institute,
Pulawy, Poland)
E. coli O157:H 272.......................Jacek Osek (Department of Microbiology,
National Veterinary Research Institute,
Pulawy, Poland)
E. coli O157:H 282.......................Jacek Osek (Department of Microbiology,
National Veterinary Research Institute,
Pulawy, Poland)
E. coli O157:H 298.......................Jacek Osek (Department of Microbiology,
National Veterinary Research Institute,
Pulawy, Poland)
E. coli O157:H 303.......................Jacek Osek (Department of Microbiology,
National Veterinary Research Institute,
Pulawy, Poland)
E. coli O157:H 306.......................Jacek Osek (Department of Microbiology,
National Veterinary Research Institute,
Pulawy, Poland)
Phage strains
	papa ................................................Our collection
	cIb2 .................................................Our collection
T4D...................................................Our collection
T4rI (r48) .........................................Karin Carlson (Department of Cell and
Molecular Biology, Uppsala University,
Sweden)
T4rIII (r67) ......................................Karin Carlson (Department of Cell and
Molecular Biology, Uppsala University,
Sweden)
P1Cm ................................................Hansjoerg Lehnherr (Department for
Biochemistry and Molecular Biology,
Institute for Microbiology, EMA-
University of Greifswald, Germany)
P1vir..................................................Our collection
24B (stx2::cat) .............................4
ST2-8624 (stx2::cat gfp) ................Gail Christie (Virginia Commonwealth
University, Richmond)
933W tox (stx2::cat)....................16
22tox (stx2::cat)...........................16
27tox (stx2::cat)...........................16
32tox (stx2::cat)...........................16
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that among standard laboratory strains this one was the most
versatile for this purpose (data not shown).
To estimate the effect of the amount of bacterial cultures
added to the top agar, we performed the series of experiments
presented in Table 2. The efficiency of plating (EOP) of two
different lambdoid phages, 	 and 24B, was highest when 1 ml
of an overnight culture (equivalent of 1.6  109 bacterial cells)
and 2 ml of the top agar were used. These conditions were then
used in testing optimal antibiotic concentrations for improve-
ment of plating of bacteriophages. The concentration finally
chosen was a compromise between enlarging plaque size and
the ability of bacteria to form a lawn in a top agar. Interest-
ingly, the amount of bacterial culture optimal for bacterio-
phage T4 plating was about 1 order of magnitude lower than
that for 	 and 24 (Table 2).
Some significant effects of the tested conditions on forma-
tion of plaques by known bacteriophages were observed (Fig.
2). Among all tested antibiotics, only addition of kanamycin
resulted in no increase in plaque sizes at any concentrations
tested, except for T4 phage, which gave bigger plaques when
this antibiotic was employed, and 	 phage, which gave bigger
plaques, though EOP did fall dramatically. The most signifi-
cant improvement in plaque sizes was observed on plates with
ampicillin at the concentration of 3 g/ml when 2 ml of the top
agar was used and 3.5 g/ml when 3 ml of the top agar was
used (Fig. 2 and Table 3 [data not shown for other antibiotics]).
However, in further experiments, we decided to use the con-
centration of 2.5 g/ml when 2 ml of the top agar was used,
which gave slightly smaller plaques, but revealed significantly
higher EOP and reproducibility of the bacterial lawn growth.
Plaques formed by phage 	papa on plates with ampicillin were
clear (Fig. 2), which might potentially be caused by a lack of
lysogen overgrowth, due to an increasing antibiotic concentra-
tion in the growth zone of the top agar. This may be also
caused by an effect observed by Chakravorty et al. (8), who
reported a loss of immunity of spheroplastized Salmonella cells
to superinfection with a phage for which they were lysogenic.
In such a situation, in the final stages of bacterial lawn growth,
lysogenic cells, which normally overgrow a center of a plaque,
could be spheroplastized and then lysed by a bacteriophage.
Addition of either chloramphenicol or tetracycline gave weak
results in the case of Shiga toxin-encoding lambdoid phages.
Nevertheless, addition of tetracycline improved the size of
FIG. 2. Formation of plaques by bacteriophages 	papa, P1Cm, and P1vir on lawns of E. coli C600 grown in LB medium or in the same medium
supplemented with one of the following antibiotics: tetracycline (LBtet), ampicillin (LBamp), chloramphenicol (LBcm), or kanamycin (LBkan). These
antibiotics were added to the bottom agar to final concentrations of 1.0, 3.5, 2.5, and 2.5 g/ml, respectively. The size scale is shown. For plate
preparation, 3 ml of the top agar and 1 ml of an overnight bacterial culture (1.6  109 CFU) were used.
TABLE 2. Dependence of EOP on amount of overnight bacterial
culture and top agar thickness
Amt of overnight
E. coli C600
culture (l)
Amt of
top agar
(ml)
EOP of strain on mediuma:
LB LBcm
(24B)	papa T4D 24B
20 3 0.36 0.82 
5  102 1.36
50 3 0.52 1 0.004 2.46
100 3 0.58 1 0.03 3.69
200 3 0.69 0.86 0.23 4.72
400 3 0.79 0.84 0.17 5.56
600 3 0.82 0.65 0.23 6.27
800 3 0.84 0.66 0.56 6.38
1,000 2 1 0.62 1 7.68
1,000 3 1 0.53 0.41 6.43
1,000 4 0.83 0.58 0.61 7.16
1,000 5 0.70 0.31 0.61 5.68
a An EOP of 1 corresponds to a maximal number of plaques obtained from the
same amount of phage lysate added to the top agar. The EOP of phage 24B
plated on LB containing chloramphenicol (LBCm) is relative to maximal plating
efficiency obtained when no antibiotic was used. The values given in the table are
relative to EOP (within each phage type) calculated from single replicates of the
same lysate, plated out at the same time using the same overnight culture. An
EOP of 1 is equivalent to 587, 146, and 503 plaques per plate for 	papa, T4D,
and 24B, respectively.
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plaques generated by phage 	 and both antibiotics showed an
ability to improve plaque size generated by phage T4. As these
antibiotics lack the ability to spheroplastize cells, one may
suggest that the effect caused by ampicillin was a sum of both
killing lysogenized cells by superinfecting phage and additional
inhibition of growth at later stages of plaque development.
Nevertheless, chloramphenicol was particularly effective in in-
creasing EOP and size of plaques generated by phages, which
possessed an artificially introduced chloramphenicol resistance
gene, namely 24B (stx2::cat), ST2-8624 (stx2::cat), 933Wtox
(stx2::cat), 22tox (stx2::cat), 27tox (stx2::cat), and
32tox (stx2::cat) (Fig. 3 and 4 and Table 4), and to some
extent P1Cm. This may be explained by an effect of a chlor-
amphenicol resistance gene present in genomes of all these
FIG. 3. Formation of plaques of bacteriophages 933Wtox (stx2::cat gfp), 22tox (stx2::cat gfp), 27tox (stx2::cat gfp), 32tox (stx2::cat gfp),
ST2-8624 (stx2::cat gfp), and 24B (stx2::cat) on lawns of E. coli C600 growing in the LB medium or in the same medium supplemented with
one of the following antibiotics: tetracycline (LBtet), ampicillin (LBamp), or chloramphenicol (LBcm). These antibiotics were added to the bottom
agar to final concentrations of 1.0, 3.5, and 2.5 g/ml, respectively. The size scale is shown. For plate preparation, 3 ml of the top agar and 1 ml
of an overnight bacterial culture (1.6  109 CFU) were used.
TABLE 3. Dependence of plaque sizes generated by bacteriophage 	 on plates with various ampicillin concentrations and
top agar thicknesses
Ampicillin
concn
(g/ml)
Mean (SD) % of total plaques within diam range (mm) ona:
Plates with 2 ml top agar Plates with 3 ml top agar
0.5 0.51–1 1.01–1.5 1.51–2 2.01–2.5 2.51 0.5 0.51–1 1.01–1.5 1.51–2 2.01–2.5 2.51
0 41.4 (2.4) 32.9 (0.8) 24.8 (0.4) 0.6 (1.0) 0.0 (0.0) 0.0 (0.0) 38.5 (8.3) 35.9 (7.9) 16.4 (10.1) 6.1 (6.8) 0.0 (0.0) 0.0 (0.0)
0.5 45.8 (0.2) 29.8 (2.6) 22.9 (0.1) 1.1 (1.8) 0.0 (0.0) 0.0 (0.0) 42.5 (0.8) 32.4 (9.0) 18.6 (4.8) 6.6 (3.4) 0.0 (0.0) 0.0 (0.0)
1.0 43.6 (1.0) 25.6 (4.2) 23.4 (2.5) 4.6 (5.3) 0.0 (0.0) 0.0 (0.0) 31.6 (4.1) 30.7 (6.2) 26.8 (0.8) 10.9 (11.1) 0.0 (0.0) 0.0 (0.0)
1.5 28.1 (0.2) 23.3 (0.5) 33.3 (13.6) 14.2 (11.8) 0.7 (1.2) 0.0 (0.0) 31.8 (2.1) 32.4 (5.7) 24.9 (5.0) 10.9 (1.4) 0.2 (0.3) 0.0 (0.0)
2.0 19.8 (0.3) 22.1 (1.6) 39.6 (12.2) 17.5 (12.1) 1.0 (1.4) 0.0 (0.0) 21.1 (3.4) 28.2 (2.3) 23.6 (3.0) 21.6 (1.7) 5.5 (3.7) 0.0 (0.0)
2.5 17.7 (3.6) 31.9 (10.5) 34.8 (1.1) 13.0 (4.2) 2.7 (3.8) 0.0 (0.0) 10.0 (3.9) 11.7 (4.9) 27.5 (1.1) 33.1 (5.7) 16.1 (0.2) 1.5 (2.2)
3.0 12.7 (0.5) 22.3 (7.0) 29.2 (9.4) 25.5 (4.6) 10.4 (2.8) 0.0 (0.0) 7.2 (3.5) 12.4 (5.2) 22.4 (0.3) 29.9 (8.9) 24.9 (1.8) 3.2 (1.6)
3.5 7.9 (0.5) 10.9 (1.4) 18.9 (8.3) 28.9 (11.7) 25.4 (14.8) 7.9 (4.2) 3.3 (4.1) 7.3 (6.6) 11.6 (10.0) 32.2 (20.3) 22.3 (14.7) 12.4 (6.3)
4.0 NA NA NA NA NA NA 3.7 (4.4) 11.2 (6.5) 16.0 (5.0) 21.3 (2.6) 30.4 (5.0) 15.6 (8.3)
4.5 NA NA NA NA NA NA 3.2 (3.6) 6.3 (5.7) 12.3 (5.4) 15.5 (3.9) 26.3 (2.9) 31.7 (17.7)
5.0 NA NA NA NA NA NA 3.4 (3.0) 4.2 (3.7) 5.2 (4.9) 13.7 (1.4) 27.9 (11.9) 39.1 (16.5)
a The mean values and standard deviations (SD) are from three experiments (calculated from plates with 100 PFU per plate). NA, not applicable because of lack
of growth of a bacterial lawn or incomplete growth of the lawn.
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phages, whose expression after infection of the host may in-
crease cellular productivity by alleviating inhibitory effects of
the antibiotic on protein production, specifically in infected
cells. In the case of other phages, the main effect might be
assumed to be caused by a slower growth of bacterial lawns:
however, tetracycline was effective in increasing the sizes of
plaques generated by lambdoid phages and T4 but was inef-
fective in the case of P1Cm. Moreover, the dependence of
efficiency of plating on the kind of antibiotic added to the
bottom agar, which was significant for lambdoid bacterio-
FIG. 4. Changes in fractions of plaques of given diameter, generated by indicated bacteriophages on E. coli C600 grown on media containing
the following antibiotics: none (open bars), 2.5 g/ml ampicillin (bars with horizontal stripes), 1 g/ml tetracycline (black bars), 2.5 g/ml
chloramphenicol (gray bars), and 2.5 g/ml kanamycin (light gray bars). The absence of a bar indicates a lack of plaques. The results of each
experiment are based on measurement of 100 to 300 plaques. Note also the information about EOP (Table 4).
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phages and P1Cm (Table 4), was not observed for T4 phage,
which plated equally well irrespective of the presence of any
antibiotic (data not shown).
To test the efficiency of the described method in isolation of
bacteriophages de novo, we tested six E. coli O157:H strains
(obtained from Jacek Osek, Department of Microbiology, Na-
tional Veterinary Research Institute, Pulawy, Poland). These
strains, cultured in LB medium, were treated with mitomycin C
(final concentration of 0.5 g/ml), and cultivation was pro-
longed to allow propagation of induced phages and liberation
of phage progeny. In the analysis of obtained lysates, we were
able to detect plaques formed by the phages only on plates with
ampicillin added to the bottom agar (Fig. 5). We failed to
detect plaques of these phages (using the same lysates) on
standard LB plates and on plates with other antibiotics. More-
over, no plaques of these phages were formed on bacterial
lawns grown on plates with minimal media (data not shown). It
is also worth mentioning that the effects of antibiotics were
significantly more pronounced than the effects of minimal me-
dia in the case of all tested phages (data not shown).
DISCUSSION
Bacteriophage plaque formation is a process which is not
fully understood yet. Although relatively many factors may
influence this process, only some of them are relatively well
studied. Thus, problems with titration of many phages, includ-
ing newly isolated strains, are quite common in the laboratory
practice. The use of antibiotics for improvement of plating
efficiency has already been proposed by Yin et al. (41); how-
ever, they added antibiotics to kill bacteria contaminating the
sample. Moreover, bacteria used for plating were resistant to
the antibiotic used; thus, the effect was not the plating im-
provement itself, but rather uncovering plaques which would
be masked by colonies of contaminating bacteria. Here, we
describe a modification of the titration procedure allowing us
to obtain relatively large plaques of phages which otherwise
give very small plaques or no plaques. The modification is
based on the use of low concentrations of antibiotics in the
bottom agar. An increase in the size of plaques, caused by low
concentrations of antibiotics in the bottom agar, might be
explained by the plaque growth kinetics, which is limited
mostly by a high host cell density. This is due to an increasing
FIG. 5. Formation of plaques of bacteriophages induced by mito-
mycin C treatment (0.5 g/ml) from E. coli O157:H strains 263, 272,
282, 298, 303, and 306 on lawns of E. coli C600 grown in LB medium
or LB medium supplemented with ampicillin (LBamp) to a final con-
centration of 3.5 g/ml. The size scale is shown.
TABLE 4. EOP of various bacteriophages using different antibiotics
Phage
EOP on mediuma:
LB LBcm LBamp LBtet LBkan
	 1.00  0.07 0.36 0.012 0.48 0.12 0.56 0.019 0.035 0.028
24b 0.048 0.016 1.00  0.11 0.22 0.051 0.22 0.058 
103
22tox 
103 1.00  0.11 0.16 0.044 0.0077 0.0058 
103
27tox 0.25 0.02 1.00 0.14 0.49 0.08 0.36 0.21 
103
32tox 0.017 0.003 1.00  0.16 0.098 0.11 
103 
103
933Wtox 
103 1.00  0.17 0.20 0.09 
103 
103
ST2-8624 
103 1.00  0.077 0.49 0.15 0.078 0.011 
103
P1vir 0.64 0.1 0.09 0.07 1.00 0.07 0.14 0.027 0.31 0.06
P1Cm 0.49 0.07 0.026 0.019 1.00  0.07 
103 
103
a The estimated EOP is relative to an average result obtained under conditions of the highest EOP. The sensitivity of 
103 means that no plaques were observed
under the given conditions. LB medium antibiotic abbreviations: cm, chloramphenicol; amp, ampicillin; tet, tetracycline; kan, kanamycin. The results presented are
average values from at least three independent experiments  standard deviation.
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depletion of virus particles by their adsorption on host cells
and fragments of lysed cells and by a physical blocking of
diffusion of phages, independently of the adsorption kinetics
(5, 14, 43). This effect can be partially overcome by using media
supporting slow growth of bacterial cells. However, the use of
media supporting slow bacterial growth may lead to a lowering
of the burst size of infected cells (23, 44). Considerably better
results obtained with the use of low ampicillin concentrations,
relative to other antibiotics, could be explained by the effect of
this antibiotic on bacterial cells and, in turn, on phage burst
size. At low concentrations, ampicillin, like other -lactam
antibiotics, causes an increase in the size of bacterial cells by
inhibiting the cell division process without decreasing the
growth of the cell mass (17). As determined previously (18),
bigger cells give larger phage burst sizes: thus, ampicillin-
treated (but still growing) cells can produce more virions. This
effect of ampicillin on phage growth may be transient as bac-
teria spheroplastized by higher concentration of penicillin
show smaller burst size (31) and bacteria lysogenized by su-
perinfecting phage may lose immunity to superinfection (8).
Moreover, at later stages of plaque formation, when antibiotic
concentration in the bacterial growth zone increases, ampicil-
lin may act synergistically to muraminolytic activities, which
are associated with some phage virions (29). This might par-
tially explain the formation of bigger plaques by phage T4D, as
even slight damage of the bacterial cell wall, mediated by
ampicillin, may trigger a lysis inhibition collapse during plaque
formation (1). The increase of plaque size observed on plates
with kanamycin, and to some extent with tetracycline, may be
an effect of a partial imbalance in the regulation of lysis inhi-
bition in the host with an impaired, but not fully suppressed,
protein synthesis system. However, in such a situation, a lack of
plaque size enlargement by addition of chloramphenicol sug-
gests that the nature of antibiotic action, not only its final
effect, may play a role in the modulation of plaque formation
by bacteriophages.
While the manuscript for this article was being revised, a
work by Comerau et al. (11) was published. Results reported in
that article may facilitate better understanding of our results.
The observation of those authors that -lactam and quinolone
antibiotics cause an increase in plaque sizes when used at
concentrations sublethal for bacterial hosts was explained par-
tially by an increase in phage burst size under such conditions.
Earlier work (40) showed that cell filamentation, especially
when caused by mitomycin C and UV light, had a similar
impact on T4 phage plaques. However, the effect was not
linked to the SOS response, which is triggered by all of these
antibiotics and UV irradiation, but rather to filamentation of
bacterial cells (see reference 11 and references therein).
Differences in susceptibility of plaque sizes to different fac-
tors (showed in this work), like the amount of bacteria in the
top agar and the kind of antibiotic used in the bottom agar,
suggest that the processes of plaque formation by different
groups of bacteriophages progress in different manners and
may depend on different factors. Ampicillin was shown to be
the most versatile agent, improving plating efficiency of lamb-
doid bacteriophages and both variants of P1. Addition of chlor-
amphenicol gave outstanding results in all lambdoid bacterio-
phages with the chloramphenicol resistance cassette inserted
into their genomes. Very poor plating efficiency of P1Cm on
plates with chloramphenicol is a surprising result, which shows
that plaque formation by this phage is dependent on different
factors from that of lambdoid phages.
During isolation of phages from environmental sources, bac-
teria which contaminate the samples may inhibit plaques’
formation by simply overgrowing a bacterial lawn. It was sug-
gested by Yin et al. (41) that one might use an antibiotic-
resistant strain and media containing this antibiotic to kill the
contaminating bacteria. Our results may suggest that environ-
mental phagologists could additionally use sublethal concen-
trations of other antibiotics to which bacteria forming a lawn
are not resistant. This may result in an increase in plaque
diameters and isolation of bacteriophages which otherwise
would be overlooked due to formation of small plaques or no
plaques. This approach may also reduce the necessity to con-
centrate samples to obtain the proper number of phages which
plate with very small efficiencies. An alternative method for
plaque size increase (24), and thus for de novo isolation of
phages, is addition of glycine to a Lactobacillus lawn (13).
However, this method does not work for E. coli phages, as
glycine does not slow E. coli growth (data not shown). When a
material from environmental samples is used for isolation of
phages which do not plate efficiently or do not plate at all,
replacement of top agar with 0.2% agarose in two-layer plates
may facilitate phages to develop normal-size plaques (21, 33,
34). One could expect that the mechanisms of plaque enlarge-
ment by sublethal antibiotic concentrations and by the use of
lowered concentration of the top agar are different, and thus
they may act synergistically. As wide spectra of antibiotics can
affect many bacterial species, they can potentially be used for
isolation of bacteriophages other than coliphages. Thus, the
method developed here may improve the ability to isolate pure
phage cultures from habitats where only metagenomic ap-
proaches have been used to date.
The ability to improve plating and plaque visibility of coli-
phages may also be used in environmental approaches like,
e.g., water quality control. One of the methods which allows for
detection of fecal contamination of water is estimation of co-
liphage load in water samples (30). The use of the method
presented in this report may allow for higher sensitivity of
detection of bacteriophages.
In summary, in the case of plating of phages which form
extremely small plaques or from which obtaining plaques is
very difficult (or even impossible) under standard conditions,
we propose to use plates supplemented with 2.5 g/ml ampi-
cillin in the bottom agar. When this approach fails, or when it
is impossible to use this antibiotic due to bacterial resistance,
other antibiotics should be tested. When an investigated phage
bears in its genome a gene responsible for resistance to an-
other antibiotic, the use of this antibiotic may also be recom-
mended.
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